GR81837B - - Google Patents

Info

Publication number
GR81837B
GR81837B GR74041A GR840174041A GR81837B GR 81837 B GR81837 B GR 81837B GR 74041 A GR74041 A GR 74041A GR 840174041 A GR840174041 A GR 840174041A GR 81837 B GR81837 B GR 81837B
Authority
GR
Greece
Prior art keywords
alk2
alk1
alkylene
image
phenyl
Prior art date
Application number
GR74041A
Other languages
Greek (el)
English (en)
Inventor
Michael Ross Johnson
Lawrence Sherman Meluin Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GR81837B publication Critical patent/GR81837B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR74041A 1983-03-14 1984-03-09 GR81837B (en, 2012)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/474,957 US4529732A (en) 1983-03-14 1983-03-14 2-[2-Hydroxy-4-(substituted)phenyl]piperidines

Publications (1)

Publication Number Publication Date
GR81837B true GR81837B (en, 2012) 1984-12-12

Family

ID=23885667

Family Applications (1)

Application Number Title Priority Date Filing Date
GR74041A GR81837B (en, 2012) 1983-03-14 1984-03-09

Country Status (8)

Country Link
US (1) US4529732A (en, 2012)
EP (1) EP0119087B1 (en, 2012)
JP (1) JPS59176255A (en, 2012)
AT (1) ATE37712T1 (en, 2012)
DE (1) DE3474445D1 (en, 2012)
DK (1) DK113984A (en, 2012)
GR (1) GR81837B (en, 2012)
IE (1) IE57030B1 (en, 2012)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2793246B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 1-aza-2-alkyl-6-aryl-cycloalcanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005536554A (ja) * 2002-08-23 2005-12-02 ユニバーシティ オブ コネチカット 新規なビフェニル及びビフェニル様カンナビノイド
WO2007127711A2 (en) * 2006-04-24 2007-11-08 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7618966B2 (en) 2006-04-24 2009-11-17 Allergan, Inc. Abnormal Cannabidiols as agents for lowering intraocular pressure
US7612101B2 (en) 2006-04-24 2009-11-03 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
US7718830B2 (en) 2006-04-24 2010-05-18 Allergan, Inc. Abnormal cannabidiols as agents for lowering intraocular pressure
JP2025522912A (ja) * 2022-07-06 2025-07-17 ヴィヴィディオン セラピューティクス， インコーポレイテッド Ｗｒｎヘリカーゼ阻害剤を含む医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498431A (en) * 1945-06-13 1950-02-21 Hoffmann La Roche 2-and 4-homocyclyl substituted piperidines
US3067204A (en) * 1959-09-16 1962-12-04 Smith Kline French Lab 2, 2-dimethyl-6-phenylpiperidine derivatives
FR1288025A (fr) * 1960-02-08 1962-03-24 Boehringer & Soehne Gmbh Procédé de préparation de nouvelles piperidones-(4) substituées en position 1, 2, 6 ou de leurs sels
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
US4306097A (en) * 1977-09-13 1981-12-15 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)phenyl]-cycloalkanol analgesic agents
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines

Also Published As

Publication number Publication date
IE57030B1 (en) 1992-03-25
US4529732A (en) 1985-07-16
DK113984D0 (da) 1984-02-28
EP0119087B1 (en) 1988-10-05
JPS59176255A (ja) 1984-10-05
IE840624L (en) 1984-09-14
ATE37712T1 (de) 1988-10-15
EP0119087A1 (en) 1984-09-19
JPS6237034B2 (en, 2012) 1987-08-10
DK113984A (da) 1984-09-15
DE3474445D1 (en) 1988-11-10

Similar Documents

Publication Publication Date Title
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
GB2061272B (en) Morpholine derivatives
EG19886A (en) Process for the preparation of new tetrazole derivatives and their use
DE3474445D1 (en) 2-(2-hydroxy-4-(substituted) phenyl) piperidines
EG16546A (en) Therapeutic agents
SE8904127D0 (sv) New biocyclic amino-substituted compounds
DE3474145D1 (en) Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
ES554474A0 (es) Un procedimiento para la preparacion de derivados de carbapenem.
DE3361789D1 (en) Cephalosporin derivatives, their preparation and medicaments containing them
DE3666223D1 (en) Anticonvulsant agents
GR81759B (en, 2012)
GR3006223T3 (en, 2012)